News and Views
Nature Biotechnology 25, 65 - 66 (2007)
doi:10.1038/nbt0107-65
Lentiviral vectors ready for prime-time
Donald B Kohn1
- Donald B. Kohn is at the University of Southern California Keck School of Medicine, Division Research Immunology/Bone Marrow Transplantation, The Saban Research Institute of Childrens Hospital Los Angeles, 4650 Sunset Blvd., Mail Stop #62, Los Angeles, California, 90027-6016, USA. e-mail: dkohn@chla.usc.edu
Abstract
The first clinical trial of a lentiviral vector highlights the promise of this new class of gene-therapy vector.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Lentiviral vectors ready for prime-timeNature Biotechnology News and Views (01 Jan 2007)
RESEARCH
Genetic therapies against HIVNature Biotechnology Research (01 Dec 2007)
Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectorsGene Therapy Original Article
See all 8 matches for Research
